March 2, 2026 | 3:00 – 3:45 PM ET
Additional sessions for EU and APAC
Based on Trinity’s 3rd Annual State of Global Market Access white paper, this webinar will take you “around the world” with focused updates on the US, Europe, Asia Pacific, and Latin America. Trinity experts will connect policy and access developments to practical implications for launch sequencing, evidence planning, pricing strategies, and in‑line optimization so teams can pressure‑test current plans and prepare for what’s next.
Webinar attendees will be among the first to receive a copy of the report.
Engage in the conversation
Attendees can also influence the discussion by submitting a question in advance of the webinar using the form below.
Key webinar topics
- United States
Evolving implications of MFN and TrumpRx, and how shifting price benchmarks and federal platforms are shaping launch, lifecycle management, and channel strategies. - Europe
Regulatory–HTA convergence through EU Joint Clinical Assessment and UK parallel MHRA–NICE reviews, and the implications of these changes for evidence requirements, timelines, and value communication. - Asia Pacific
Transition to a multi-tier funding model, NRDL value-based negotiations, the Commercial Innovative Drug List (Category C), along with the growing role of real-world evidence and early access platforms. - Latin America
HTA and pricing reforms, the increasing focus on local manufacturing and technology transfer, and emerging considerations for high-cost therapies, including cell and gene therapies. - Cross-regional implications
How these trends collectively impact launch sequencing, portfolio strategy, contracting approaches, and global value narratives for pharma, biotech, and medtech companies.
Which session would you like to register for?
Complete the form below to register for the March 2nd session at 3:00 PM ET
Complete the form below to register for the March 3rd session at 12:00 UTC+8 – Asia
Complete the form below to register for the March 3rd session at 12:00 CET – Europe
By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.